The proteoglycans in the cancer pathway also show significant involvement, with 10 genes and an FDR of 1.75 × 10−6, encompassing genes such as MMP2, FGF2, and PKAc, which are associated with extracellular matrix remodelling and tumour microenvironment regulation. The gene discussed is MMP2; the disease is neoplasm.